These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24402707)

  • 41. Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development.
    Liu Y; Dong Z; Liang J; Guo Y; Guo X; Shen S; Kuang G; Guo W
    Tumour Biol; 2016 Apr; 37(4):5621-32. PubMed ID: 26577858
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
    Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
    J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PTEN gene is infrequently hypermethylated in human esophageal squamous cell carcinoma.
    Sun Z; Ji N; Bi M; Wang S; Liu X; Wang Z
    Tumour Biol; 2015 Aug; 36(8):5849-57. PubMed ID: 25724185
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aberrant promoter methylation and reduced expression of p16 gene in esophageal squamous cell carcinoma from Kashmir valley: a high-risk area.
    Salam I; Hussain S; Mir MM; Dar NA; Abdullah S; Siddiqi MA; Lone RA; Zargar SA; Sharma S; Hedau S; Basir SF; Bharti AC; Das BC
    Mol Cell Biochem; 2009 Dec; 332(1-2):51-8. PubMed ID: 19513816
    [TBL] [Abstract][Full Text] [Related]  

  • 45. RHCG Suppresses Tumorigenicity and Metastasis in Esophageal Squamous Cell Carcinoma via Inhibiting NF-κB Signaling and MMP1 Expression.
    Ming XY; Zhang X; Cao TT; Zhang LY; Qi JL; Kam NW; Tang XM; Cui YZ; Zhang BZ; Li Y; Qin YR; Guan XY
    Theranostics; 2018; 8(1):185-198. PubMed ID: 29290801
    [No Abstract]   [Full Text] [Related]  

  • 46. Metastasis-suppressing NID2, an epigenetically-silenced gene, in the pathogenesis of nasopharyngeal carcinoma and esophageal squamous cell carcinoma.
    Chai AW; Cheung AK; Dai W; Ko JM; Ip JC; Chan KW; Kwong DL; Ng WT; Lee AW; Ngan RK; Yau CC; Tung SY; Lee VH; Lam AK; Pillai S; Law S; Lung ML
    Oncotarget; 2016 Nov; 7(48):78859-78871. PubMed ID: 27793011
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Inactivation of PMS2 gene by promoter methylation in nasopharyngeal carcinoma].
    Ni HF; Jiang B; Zhou Z; Li Y; Yuan XY; Cao XL; Huang GW
    Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):812-817. PubMed ID: 27998438
    [No Abstract]   [Full Text] [Related]  

  • 48. MAL hypermethylation is a tissue-specific event that correlates with MAL mRNA expression in esophageal carcinoma.
    Jin Z; Wang L; Zhang Y; Cheng Y; Gao Y; Feng X; Dong M; Cao Z; Chen S; Yu H; Zhao Z; Zhang X; Liu J; Mori Y; Fan X; Meltzer SJ
    Sci Rep; 2013 Oct; 3():2838. PubMed ID: 24088706
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Concordant promoter methylation of transforming growth factor-beta receptor types I and II occurs early in esophageal squamous cell carcinoma.
    Dong Z; Guo W; Guo Y; Kuang G; Yang Z
    Am J Med Sci; 2012 May; 343(5):375-81. PubMed ID: 22314103
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Decreased expression of RUNX3 is correlated with tumor progression and poor prognosis in patients with esophageal squamous cell carcinoma.
    Sugiura H; Ishiguro H; Kuwabara Y; Kimura M; Mitsui A; Mori Y; Ogawa R; Katada T; Harata K; Fujii Y
    Oncol Rep; 2008 Mar; 19(3):713-9. PubMed ID: 18288406
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Methylation-mediated gene silencing of suppressor of cytokine signaling-1 (SOCS-1) gene in esophageal squamous cell carcinoma patients of Kashmir valley.
    Hussain S; Singh N; Salam I; Bandil K; Yuvaraj M; Akbar Bhat M; Muzaffar Mir M; Siddiqi MA; Sobti RC; Bharadwaj M; Das BC
    J Recept Signal Transduct Res; 2011 Apr; 31(2):147-56. PubMed ID: 21385099
    [TBL] [Abstract][Full Text] [Related]  

  • 52. FOXQ1 promotes esophageal cancer proliferation and metastasis by negatively modulating CDH1.
    Pei Y; Wang P; Liu H; He F; Ming L
    Biomed Pharmacother; 2015 Aug; 74():89-94. PubMed ID: 26349968
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Promoter methylation regulates cigarette smoke-stimulated cyclooxygenase-2 expression in esophageal squamous cell carcinoma.
    Meng XY; Zhu ST; Zhou QZ; Li P; Wang YJ; Zhang ST
    J Dig Dis; 2012 Apr; 13(4):208-13. PubMed ID: 22435505
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Decitabine enhances tumor recognition by T cells through upregulating the MAGE-A3 expression in esophageal carcinoma.
    Shi X; Chen X; Fang B; Ping Y; Qin G; Yue D; Li F; Yang S; Zhang Y
    Biomed Pharmacother; 2019 Apr; 112():108632. PubMed ID: 30797153
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of aberrant promoter methylation of EDNRB gene in esophageal squamous cell carcinoma.
    Zhao BJ; Sun DG; Zhang M; Tan SN; Ma X
    Dis Esophagus; 2009; 22(1):55-61. PubMed ID: 18564167
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Promoter hypermethylation and quantitative expression analysis of CDKN2A (p14ARF and p16INK4a) gene in esophageal squamous cell carcinoma.
    Ito S; Ohga T; Saeki H; Watanabe M; Kakeji Y; Morita M; Yamada T; Maehara Y
    Anticancer Res; 2007; 27(5A):3345-53. PubMed ID: 17970080
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Elevated expression of MDR1 associated with Line-1 hypomethylation in esophageal squamous cell carcinoma.
    Zhu J; Ling Y; Xu Y; Lu MZ; Liu YP; Zhang CS
    Int J Clin Exp Pathol; 2015; 8(11):14392-400. PubMed ID: 26823755
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Up-regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinoma.
    Hu L; Wu Y; Tan D; Meng H; Wang K; Bai Y; Yang K
    J Exp Clin Cancer Res; 2015 Jan; 34(1):7. PubMed ID: 25613496
    [TBL] [Abstract][Full Text] [Related]  

  • 59. RASSF1A gene promoter methylation in esophageal cancer specimens.
    Yamaguchi S; Kato H; Miyazaki T; Sohda M; Kimura H; Ide M; Asao T; Kuwano H
    Dis Esophagus; 2005; 18(4):253-6. PubMed ID: 16128782
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma.
    Wong ML; Tao Q; Fu L; Wong KY; Qiu GH; Law FB; Tin PC; Cheung WL; Lee PY; Tang JC; Tsao GS; Lam KY; Law S; Wong J; Srivastava G
    Int J Oncol; 2006 Mar; 28(3):767-73. PubMed ID: 16465383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.